Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07097285

The Effect of Sensory Awareness Training Given to Women of Reproductive Age on Dysmenorrhea and Kinesiophobia

This research investigates the use of web-based sensory awareness training given to women of reproductive age. It was planned to examine the effect of dysmenorrhea level and kinzeophobia status.H0a = Body weight of women of reproductive age who received and did not receive sensory awareness training. There is no difference between awareness levels.

H1a = Body size of women of reproductive age who receive and do not receive sensory awareness training. There is a difference between awareness levels.

H0b = Dysmenorrhea of women of reproductive age who received or did not receive sensory awareness training. There is no difference between the levels.

H1b = Dysmenorrhea among women of reproductive age who received and did not receive sensory awareness training. There is a difference between the levels.

H0c = Kinesiophobia in women of childbearing age who received or did not receive sensory awareness training. There is no difference between the situations.

H1c = Kinesiophobia in women of reproductive age who receive and do not receive sensory awareness training. There is a difference between situations Sensory awareness training was given to women in the intervention group of the study for 4 weeks. will be given. Training contents, Sensory System Training Presentation, Proprioception and Kinesthesia Sensory Training Presentation, Interoception Sense Training Presentation will be given, then Graded Sensory Discrimination, Graded Motor Imagery (DMI), interoception awareness training, body training with training consisting of interoceptive awareness exercises and home exercise programs. A protocol for awareness training will be implemented.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Dysmenorrhea Anxiety Disorders Kinesiophobia Menstruation Disturbances Mental Disorders Neurologic Manifestations Pain Pathologic Processes Pathological Conditions, Signs and Symptoms Pelvic Pain Phobic Disorders Signs and Symptoms

Age range

19 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Sağlık Bilimleri Üniversitesi

Istanbul, Turkey (Türkiye)

About this study

Sensory awareness training was given to women in the intervention group of the study for 4 weeks will be given. Training contents, Sensory System Training Presentation, Proprioception and Kinesthesia Sensory Training Presentation, Interoception Sense Training Presentation will be given, then Graded Sensory Discrimination, Graded Motor Imagery (DMI), interoception awareness training, body training with training consisting of interoceptive awareness exercises and home exercise programs.

A protocol for awareness training will be implemented. Each training is 60 minutes long will be planned. Women who volunteered to participate in the study and were assigned to the intervention group An informational meeting will be held before the training. 4 weeks from pre-training and first training "Tampa Kinesiophobia Scale (TKÖ)" "Dysmenorrhea Affectedness Scale" and "Very Dimensional Body Awareness Assessment-II Scale" will be applied. be once a week Each training period is limited to 60 minutes. Research forms were given to participants face to face. will be implemented.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Volunteering to participate in research
  • Having a complaint of dysmonea
  • Being of childbearing age
  • Being over 19 years old
  • Having internet access
  • Having a smart mobile phone

Exclusion criteria

  • Be pregnant
  • Having any disease that affects the menstrual period
  • Using oral contraceptives
  • Using intrauterine device

Treatment and study plan

sensory awareness training

Behavioral

Presentations to inform during training will be done, then Graded Sensory Discrimination, Graded Motor Imagery (DMI) and a home exercise program, as well as a body awareness training program. protocol will be applied. Graded Sensory Discrimination protocol, localization training It includes level 1, localization training level 2 and graphesthesia training. Graded Engine Visualization (DMI) protocol includes right/left discrimination training and visual imagery training.

Primary outcomes

  1. Introductory Information Form

    Time frame: Baseline

    In this form created by researchers based on the literature, There are questions about the participants' age, the high school they graduated from, dysmenorrhea and kinesiophobia is taking.

  2. Tampa Kinesiophobia Scale

    Time frame: day 1

    Tampa Kinesiophobia Scale (TCS) Miller, Kori and Todd It is a scale developed by in 1991. Fear of movement and re-injury, and It was developed to evaluate avoidance behavior due to fear. It was adapted to Turkish by Yılmaz et al. in 2011 and tested for validity and reliability. study has been done. The scale consists of 17 questions. On the scale, "1" means "strongly disagree" and "2" means "strongly disagree." from "1" to "4", where "I disagree", "3" I agree, "4" I completely agree. Varying Likert scoring is used. An individual can get a total score between 17-68, A high score indicates that the individual has high kinesiophobia.

  3. Dysmenorrhea Affect Scale

    Time frame: day 1

    Validity and reliability study by Gün (2014) The Dysmenorrhea Exposure Scale (DES) was used to measure women's periods of menstrual pain. It is designed to identify problems and coping methods. A total of items 39 and 11 It consists of sub-dimensions. The Cronbach's Alpha coefficient of the scale is 0.90. Participants each rated the item on a 5-point scale ranging from 'I totally disagree (1)' to 'I totally agree (5)'. It evaluates on a Likert type scale. As the score obtained from the scale increases, people's The level of being affected by dysmenorrhea also increases. The lowest score that can be obtained from the scale is , The highest score is 195.

  4. Multidimensional Body Awareness Assessment-II Scale

    Time frame: day 1

    Body Awareness has multiple developed by Mehling, Acree, Stewart, Silas and Jones to measure the dimensions of The Turkish adaptation of the scale was made by Mungurlar and Kahya. Scale, It is a self-report scale consisting of one item and eight factors. These factors; "Noticing", "Attention "Not Distracting", "Not Worrying", "Regulating Attention", "Emotional Awareness", "Self-Regulation", "Listening to the Body" and "Trusting". Evaluation of the scale is 1-5 points and is made by averaging the scoring factors separately. of scale Validity reliability Cronbach's alpha coefficient was determined as 0.88. As the score obtained from the scale increases, it means that people have more positive body awareness.

Secondary outcomes

  1. Tampa Kinesiophobia Scale

    Time frame: up to 4 weeks

    Tampa Kinesiophobia Scale (TCS) Miller, Kori and Todd It is a scale developed by in 1991. Fear of movement and re-injury, and It was developed to evaluate avoidance behavior due to fear. It was adapted to Turkish by Yılmaz et al. in 2011 and tested for validity and reliability. study has been done. The scale consists of 17 questions. On the scale, "1" means "strongly disagree" and "2" means "strongly disagree." from "1" to "4", where "I disagree", "3" I agree, "4" I completely agree. Varying Likert scoring is used. An individual can get a total score between 17-68, A high score indicates that the individual has high kinesiophobia.

  2. Dysmenorrhea Affect Scale

    Time frame: up to 4 weeks

    Validity and reliability study by Gün (2014) The Dysmenorrhea Exposure Scale (DES) was used to measure women's periods of menstrual pain. It is designed to identify problems and coping methods. A total of items 39 and 11 It consists of sub-dimensions. The Cronbach's Alpha coefficient of the scale is 0.90. Participants each rated the item on a 5-point scale ranging from 'I totally disagree (1)' to 'I totally agree (5)'. It evaluates on a Likert type scale. As the score obtained from the scale increases, people's The level of being affected by dysmenorrhea also increases. The lowest score that can be obtained from the scale is , The highest score is 195.

  3. Multidimensional Body Awareness Assessment-II Scale

    Time frame: up to 4 weeks

    Body Awareness has multiple developed by Mehling, Acree, Stewart, Silas and Jones to measure the dimensions of The Turkish adaptation of the scale was made by Mungurlar and Kahya. Scale, It is a self-report scale consisting of one item and eight factors. These factors; "Noticing", "Attention "Not Distracting", "Not Worrying", "Regulating Attention", "Emotional Awareness", "Self-Regulation", "Listening to the Body" and "Trusting". Evaluation of the scale is 1-5 points and is made by averaging the scoring factors separately. of scale Validity reliability Cronbach's alpha coefficient was determined as 0.88. As the score obtained from the scale increases, it means that people have more positive body awareness.

Study contacts

Contact information is provided by the study sponsor or research team.

Büşra HIZLIOL, Arş. Gör.

CONTACT

[email protected]

0539 408 22 07

Yasemin AYDIN KARTAL, Doç. Dr.

CONTACT

[email protected]

0543 287 00 29

Sponsors and collaborators

Lead sponsor

Saglik Bilimleri Universitesi

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jul 31, 2025
Registry last updated
Aug 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.